|Organic compounds -- part of the class 532-570 series patents - Monitor Patents|
USPTO Class 536 | Browse by Industry: Previous - Next | All
Recent | 14: | Sep | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan | 13: Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan | 12: Dec | Nov | Oct | Sep | Aug | July | June | May | April | Mar | Feb | Jan | 11: Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan | 10: Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan | | 09: Dec | Nov | Oct | Sep | Aug | Jl | Jn | May | Apr | Mar | Fb | Jn | | 2008 | 2007 |
Organic compounds -- part of the class 532-570 seriesBelow are recently published patent applications awaiting approval from the USPTO. Recent week's RSS XML file available below.
Listing for abstract view: USPTO application #, Title, Abstract excerpt,Patent Agent. Listing format for list view: USPTO National Class full category number, title of the patent application. 10/02/2014 > 14 patent applications in 11 patent subcategories.
20140296496 - Method for extracting brown algae polysaccharide via microwave chemical process: This invention relates to an extraction process of brown algae polysaccharides in a field of pharmaceutical chemistry. This invention particularly discloses a process of extracting brown algae polysaccharides based on a microwave chemistry method and brown algae polysaccharides obtained by said process. The process of the invention comprises: 1) putting... Agent:
20140296497 - Method for producing myo-inositol and myo-inositol derivative: [Problem] To impart significantly improved myo-inositol producing capability, suitable for use in recombinant DNA techniques and synthetic biology methods, to a host microorganism that does not possess an endogenous myo-inositol biosynthesis pathway, such as Escherichia coli. [Solution] Inositol monophosphatase activity is strengthened in a transformant obtained by introducing a myo-inositol... Agent:
20140296498 - Tiacumicin production: Methods, processes and materials for the production and recovery of Tiacumicins produced by culturing a microorganism belonging to the species Dactylosporangium aurantiacum subspecies hamdenensis having the ability to produce and accumulate one or more Tiacumicin in a nutrient medium comprising a carbon source, a nitrogen source, trace elements such as... Agent: Optimer Pharmaceuticals, Inc.
20140296499 - Novel process for the preparation of rebaudioside d and other related naturally occurring sweetners: A novel process for preparation of Rebaudioside D (RD), and other related naturally occurring sweeteners is provided. RD is a natural sweetening agent which can decrease the bitter aftertaste of steviol glycosides. The said process is suitable for commercial manufacturing by using readily available natural products and nontoxic reagents.... Agent:
20140296501 - Aptamers and diagnostic methods for detecting the egf receptor: The present invention provides aptamers that specifically bind to the EGF receptor in a sample, and diagnostic and analytical methods using those aptamers.... Agent:
20140296500 - Methods and compositions of nucleic acid ligands for detection of clinical analytes related to human health: Specific DNA sequences for binding various clinically relevant analytes from the human body are described. Each of these sequences or their linear, two- and three-dimensional linked sequences can function in varying assay and sensor formats with varying degrees of success. Linkage of the whole or partial DNA sequences (putative binding... Agent: Otc Biotechnologies, LLC
20140296504 - Hepatitis b viral variants with reduced susceptibility to nucleoside analogs and uses thereof: The present invention relates generally to viral variants exhibiting reduced sensitivity to particular agents and/or reduced interactivity with immunological reagents. More particularly, the present invention is directed to hepatitis B virus (HBV) variants exhibiting complete or partial resistance to nucleoside or nucleotide analogs and/or reduced interactivity with antibodies to viral... Agent: Abl Sa
20140296502 - Antisense design: A novel class of pharmaceuticals which comprises a Locked Nucleic Acid (LNA) which can be used in antisense therapy. These novel oligonucleotides have improved antisense properties. The novel oligonucleotides are composed of at least one LNA selected from beta-D-thio/amino-LNA or alpha-L-oxy/thio/amino-LNA. The oligonucleotides comprising LNA may also include DNA and/or... Agent: Santaris Pharma A/s
20140296503 - Isolated dsrna molecules and methods of using same for silencing target molecules of interest: An isolated dsRNA molecule comprising an antisense RNA sequence for regulating a target gene of interest in a plant or a phytopathogen of the plant, wherein the dsRNA sequence is flanked by two complementary sites to an smRNA or smRNAs expressed in the plant and wherein the dsRNA molecule further... Agent:
20140296505 - Compositions and methods for bacterial production of chondroitin: The invention relates to the field of recombinant DNA technology for the production of chondroitin, including the production of chondroitin sulfate via a combination of recombinant bacterial fermentation and post-fermentation sulfation.... Agent: DsmIPAssets B.v.
20140296506 - Glucopyranoside compound: wherein Ring A and Ring B are: (1) Ring A is an optionally substituted unsaturated monocyclic heterocyclic ring, and Ring B is an optionally substituted unsaturated monocyclic heterocyclic ring, an optionally substituted unsaturated fused heterobicyclic ring, or an optionally substituted benzene ring, (2) Ring A is an optionally substituted benzene... Agent:
20140296507 - Polymer hydrogels and methods of preparation thereof: The invention relates to a method for the preparation of a polymer hydrogel, comprising cross-linking a precursor comprising a hydrophilic polymer optionally in combination with a second hydrophilic polymer, using a polycarboxylic acid as the cross-linking agent. The invention further concerns the polymer hydrogel obtainable by the method of the... Agent: Gelesis LLC
20140296509 - Polyol and polyether iron oxide complexes as pharmacological and/or mri contrast agents: Iron oxide complexes, pharmacological compositions and unit dosage thereof, and methods for their administration, of the type employing an iron oxide complex with a polyol, are disclosed. The pharmacological compositions employ a polysaccharide iron oxide complex, wherein the polysaccharide is a modified polyol such as a carboxyalkylated reduced dextran. The... Agent:
20140296508 - Process for the preparation of trivalent iron complexes with mono-, di- and polysaccharide sugards: Process for the preparation of trivalent iron complexes with mono-, di- and polysaccharide sugars, consisting of the activation of the sugar by oxidation with nascent bromine generated in situ by reaction between an alkaline or alkaline earth bromine and an alkaline hypochlorite, the complexation of the activated sugar in solution... Agent: Biofer S.p.a.09/25/2014 > 14 patent applications in 11 patent subcategories.
20140288286 - Method of extracting and isolation flavonoids from euphorbia cuneata: The present invention relates to methods to isolate flavonoids from Euphorbia cuneata, and a pharmaceutical composition comprising the flavonoids or the extracts or both of them for a use as anti-ulcer agent. The present invention further relates to a method to isolate a compound selected from the group consisting of... Agent:
20140288287 - Sequence-determined dna fragments encoding trehalose-6p phosphatase proteins: The present invention provides DNA molecules that constitute fragments of the genome of a plant, and polypeptides encoded thereby. The DNA molecules are useful for specifying a gene product in cells, either as a promoter or as a protein coding sequence or as an UTR or as a 3′ termination... Agent:
20140288288 - Anti-cd19 antibodies with reduced immunogenicity: Anti-CD19 B4 antibodies with modified variable regions are disclosed. The modified anti-CD19 variable region polypeptides have alterations to one or more framework regions or complementarity determining regions of the heavy chain variable region or light chain variable region, thereby to reduce a T-cell response.... Agent: Merck Patent Gmbh
20140288289 - Method for detecting and quantifying wheat endogenous gene: Provided is a method of detecting or quantifying a wheat species-specific DNA in a test sample by polymerase chain reaction. The method comprises a step of amplifying a nucleic acid molecule having at partial sequence of a nucleotide sequence identified as SEQ ID NO: 1 using a nucleic acid molecule... Agent: Nisshin Seifun Group Inc.
20140288290 - Antisense design: A novel class of pharmaceuticals which comprises a Locked Nucleic Acid (LNA) which can be used in antisense therapy. These novel oligonucleotides have improved antisense properties. The novel oligonucleotides are composed of at least one LNA selected from beta-D-thio/amino-LNA or alpha-L-oxy/thio/amino-LNA. The oligonucleotides comprising LNA may also include DNA and/or... Agent:
20140288291 - Compounds and methods for modulating protein expression: The present invention provides compounds and methods for modulating expression of a protein, including, but not limited to, modulating splicing of a pre-mRNA to modulate the amount of one or more variants of a protein.... Agent: Isis Pharmaceuticals, Inc.
20140288292 - Methods and compositions for the specific inhibition of beta-catenin by double-stranded rna: This invention relates to compounds, compositions, and methods useful for reducing β-catenin target RNA and protein levels via use of dsRNAs, e.g., Dicer substrate siRNA (DsiRNA) agents.... Agent:
20140288293 - Compositions and methods for nucleic acid extraction: Compositions and methods for the efficient extraction, enrichment and isolation of nucleic acids from fresh, fixed or fixed and embedded cells, tissues, biological materials and cellular source material.... Agent:
20140288294 - Antiviral compounds: The invention is related to phosphorus substituted anti-viral inhibitory compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.... Agent: Gilead Sciences, Inc.
20140288295 - Oligomer conjugates of heteropentacyclic nucleosides: The invention provides small molecule drugs that are chemically modified by covalent attachment of a water-soluble oligomer.... Agent:
20140288296 - Cellulose films with at least one hydrophobic or less hydrophilic surface: A method for the production of cellulose films with at least one hydrophobic or less hydrophilic surface, or with at least one surface with a water contact angle (θ) in a range from 55° to less than 100° is described. The method involves contacting the cellulose material with a hydrophobic... Agent:
20140288298 - Method for manufacturing monosaccharides, oligosaccharides, and furfurals from biomass: The present invention provides a method for efficiently producing monosaccharides, oligosaccharides, and furfurals from biomass. A biomass is hydrolyzed under conditions under which monosaccharides, oligosaccharides, and furfurals are produced while continuously supplying an aqueous suspension of the biomass from a supply port of a continuous primary hydrolysis device and moving... Agent: Oji Holdings Corporation
20140288297 - Polysaccharide derived materials: A mesoporous material is derived from a polysaccharide by thermally assisted partial carbonisation after expansion. The polysaccharide is an acid containing polysaccharide or mixture of polysaccharides.... Agent: The University Of York
20140288299 - Process: The present invention relates to a process for preparing a short oligonucleotide comprising the steps of: (i) preparing a crude mixture comprising the oligonucleotide (ii) subjecting the mixture formed in step (i) to a desalting step; wherein the process does not comprise a chromatographic purification step.... Agent: Santaris Pharma A/s09/18/2014 > 18 patent applications in 14 patent subcategories.
20140275502 - Process for the preparation of certain triaryl rhamnose carbamates: Aryl boronic esters and boronic acids containing the rhamnose carbamate moiety are coupled to a triazole with an appropriate leaving group, generating a 4-triazolylphenyl carbamate in good yield and without cleavage of the carbamate linkage.... Agent: Dow Agrosciences LLC
20140275503 - Process for the preparation of certain triaryl rhamnose carbamates: Aryl boronic esters and boronic acids containing the rhamnose carbamate moiety are prepared by coupling a boronate substituted phenyl isocyanate with a tetrahydropyran-2-ol in the presence of cesium carbonate.... Agent: Dow Agrosciences LLC
20140275504 - Process for the preparation of certain triaryl rhamnose carbamates: Aryl boronic esters containing the rhamnose carbamate moiety are prepared in good yield and without cleavage of the carbamate linkage by first contacting p-bromophenyl isocyanate with a tetrahydropyran-2-ol followed by reaction with a diboron compound.... Agent: Dow Agrosciences LLC
20140275505 - Process for the preparation of certain triaryl rhamnose carbamates: Triaryl rhamnose carbamate insecticides are prepared from triaryl carbamates and the tetrahydropyran-2-ols in good yield without the use of a hydride base.... Agent: Dow Agrosciences LLC
20140275506 - Alkenyl glycosides and their preparation: An alkenyl glycoside is prepared by reacting a metathesis-derived unsaturated fatty alcohol containing 10 to 30 carbon atoms with either (1) a reducible monosaccharide or composition hydrolyzable to a reducible monosaccharide, or (2) a hydrocarbyl glycoside produced by reacting an alcohol containing up to 6 carbon atoms with a reducible... Agent: Elevance Renewable Sciences, Inc.
20140275507 - Processes for isolating chitin and chitosan from fungal biomass: Methods of extracting chitin and chitosan from fungal biomass using a solution of one or more ammonia compounds, amines, and/or alkaline silicate compounds. The solution dissolves and extracts amino acids, fatty acids and other carbohydrates from the fungal cells leaving chitin and/or chitosan, and the extractant may be recovered from... Agent:
20140275508 - Artificial nucleic acids: Artificial nucleosides including 2-methyl-nucleobase-substituted butane-1,3-diol nucleosides are disclosed. Four different stereoisomers of such nucleosides are possible. Oligonucleotides made up of the artificial nucleosides form homoduplexes of greater stability than DNA duplexes and have a reduced ability to hybridize to DNA or RNA.... Agent: Elitech Holding B.v.
20140275509 - Multifunctionalized materials: The present invention describes a method for producing multifunctional materials comprising the steps of: a) chemically activating functional groups present in a micro- or nanoparticulate base material; b) performing a nucleophilic substitution reaction between at least one terminal amino, carboxyl or thiol group of a PNA or DNA type A... Agent: Fundació N Agencia Aragonesa Para La Investigació N Y El Desarollo
20140275510 - Compositions and methods for nucleic acid extraction: Compositions and methods for the efficient extraction, enrichment and isolation of nucleic acids from fresh, fixed or fixed and embedded cells, tissues, biological materials and cellular source material.... Agent: Abbott Molecular Inc.
20140275511 - Purification of nikkomycin z: This invention relates to an improved method of purifying Nikkomycin Z, an antifungal compound shown to be particularly useful in treating Valley Fever, coccidioidomycosis. The improvement of this invention lies in the choice of resins and elution conditions, chosen to minimize handling of the material.... Agent:
20140275512 - Preparation of malto-oligosaccharides: Disclosed is a method for preparing a mixture of malto-oligosaccharides. Generally, a dry-milled corn fraction, such as a corn flour from which germ and fiber have been removed, is subjected to hydrolysis, typically catalyzed with acid or an enzyme such as an α-amylase enzyme, under conditions suitable to form a... Agent:
20140275514 - Methods for digestion of cellulosic biomass solids in the presence of a phenolic solvent: Digestion of cellulosic biomass solids can be enhanced in the presence of a phenolic solvent. Methods for digesting cellulosic biomass solids can comprise providing cellulosic biomass solids in a digestion medium comprising a phenolic solvent; and heating the cellulosic biomass solids and the digestion medium in a digestion unit in... Agent: Shell Oil Company
20140275513 - Methods for digestion of cellulosic biomass solids in the presence of a phenolic solvent generated in situ from lignin: Digestion of cellulosic biomass solids can be enhanced in the presence of a phenolic solvent. Methods for digesting cellulosic biomass solids can comprise providing cellulosic biomass solids in a digestion medium comprising water and an organic solvent; heating the cellulosic biomass solids and the digestion medium in a digestion unit... Agent: Shell Oil Company
20140275515 - Methods for digestion of cellulosic biomass solids in the presence of a phenolic solvent generated in situ from lignin: Digestion of cellulosic biomass solids can be enhanced in the presence of a phenolic solvent. Methods for digesting cellulosic biomass solids can comprise providing cellulosic biomass solids containing up to about 50% water by mass in a digestion medium comprising about 50% or more of an organic solvent by volume;... Agent: Shell Oil Company
20140275516 - Naturally derived mixed cellulose esters and methods relating thereto: Mixed cellulose esters derived from natural products (e.g., natural cellulose esters) may be produced by methods that include acylating a cellulose with a natural esterification reactant or a derivative thereof to yield a natural cellulose ester. In some instances, the natural esterification reactant derivative may be a saponified natural esterification... Agent: Celanese Acetate LLC
20140275517 - Methods and systems for conditioning of particulate crystalline materials: Methods and systems for the preparation of conditioned micronized active agents. Additionally, methods and systems for in-process conditioning of micronized active agent particles and compositions comprising conditioned micronized materials.... Agent: Pearl Therapeutics, Inc.
20140275518 - L-glucose production from l-glusose/l-mannose mixtures using simulated moving bed separation: Disclosed is a process for the production of L-glucose from a mixture of L-mannose and L-glucose to provide a high purity L-glucose product. More particularly, the invention relates to a process for the isomerization of mixtures of L-mannose and L-glucose to favor the epimerization or transformation of the L-mannose into... Agent: Orochem Technologies, Inc.
20140275519 - Process for the ultrapurification of alginates: A method for obtaining solutions of non-structurally modified salts of alginate, with endotoxin content less than 20 EU/g includes obtaining an alginate solution having a concentration ranging from 1.6 to 2.0% by weight by adding commercial grade alginate powder to a saline solution. The alginate solution obtained is filtered on... Agent: Gh Care, Inc. D/b/a Altucell, Inc.09/11/2014 > 22 patent applications in 10 patent subcategories.
20140256921 - Method for producing tetrahydropyran compound and intermediate thereof: Disclosed is a method for producing a tetrahydropyran compound represented by general formula (5) shown in the scheme. Accordingly, a tetrahydropyran derivative is obtained in high yield and with high selectivity without using a highly toxic reagent, and an industrially useful method for producing a tetrahydropyran derivative and an intermediate... Agent: Nissan Chemical Industries, Ltd.
20140256922 - Toll-like receptor-7 and -8 modulatory 1h imidazoquinoline derived compounds: The present disclosure provides novel imidazoquinoline derived compounds, derivatives thereof, analogues thereof, and pharmaceutically acceptable salts thereof, and methods of making and using such compounds. The present disclosure also provides TLR7 agonists and TLR7/TLR8 dual agonists, probes, tissue-specific molecules, adjuvants, immunogenic compositions, therapeutic compositions, and self-adjuvanting vaccines including the imidazoquinoline... Agent:
20140256923 - Novel compound, method for producing same, and use of same: A compound represented by the following Structural Formula (A) or a salt thereof. The compound or the salt thereof is suitably produced from a microorganism belonging to the genus Saccharothrix and can be suitably used as a prostaglandin production inhibitor.... Agent: Microbial Chemistry Research Foundation
20140256924 - Carbohydrate functionalised surfaces: Carbohydrates are biomolecules that are involved in a range of biological processes and play key roles in, for instance, host immune response and cellular adhesion. Accordingly, functionalisation of medical devices such as stents, valves, catheters, prostheses and other devices for in vivoimplantation with carbohydrates is an area in which considerable... Agent: The Provost, Fellows, Foundation Scholars And The Other Members Of Board Of
20140256925 - Composite materials: A composite material is formed by combining an expandable polymer having a charge with another polymer having an opposite charge to produce. In particular, the composite material can be prepared by combining the polymers with a medium such as and water, and expanding the mixture using a treatment that expands... Agent: The Penn State Research Foundation
20140256927 - Increasing the lipid content in microalgae by genetically manipulating a triacylglycerol (tag) lipase: The present invention relates to a method of increasing the lipid content in an organism, in particular a micro algae by modulating the activity of a triacylglycerol (TAG) lipase. The invention also concerns organisms produced by this method, or microalgae, with increased lipid content, as well as their use in... Agent:
20140256926 - Ionic tags for synthesis of oligoribonucleotides: The invention relates to the chemical synthesis of oligonucleotides, e.g., oligoribonucleotides. In another aspect, the invention relates to compounds of formula (II) processes for making these compounds, and the use thereof in the chemical synthesis of oligonucleotides, e.g., oligoribonucleotides. The invention also relates to methods of synthesis of oligomers, including... Agent: The Royal Institution For The Advancement Of Learning/mcgill University
20140256929 - Extraction buffer and method for isolating high-quality rna from cells exposed to metal chloride solutions and clay mineral suspensions: An RNA extraction buffer, an RNA extraction method, and an RNA extraction kit are described which enable functional, rapid, efficient, and high-quality RNA isolation from samples containing high concentrations of aqueous metal cations, clays, silica, or silicate minerals... Agent:
20140256930 - Enzyme function modification method and enzyme variant thereof: An object of the present invention is to provide a method for converting the coenzyme dependency of enzymes of the medium-chain dehydrogenase/reductase (MDR) family. A further object of the present invention is to provide enzyme variants of the MDR family whose coenzyme dependency is converted by the conversion method and... Agent: Kaneka Corporation
20140256931 - Carbonaceous material for purifying lignocellulosic oligomers: The present disclosure relates carbonaceous materials and to methods of using such carbonaceous materials for purifying oligomers produced from depolymerized biomass, such as lignocellulosic biomass.... Agent: The Regents Of The University Of CaliforniaPrevious industry: Organic compounds -- part of the class 532-570 series
Next industry: Organic compounds -- part of the class 532-570 series
RSS FEED for 20141002:
Integrate FreshPatents.com into your RSS reader/aggregator or website to track weekly updates.
For more info, read this article.
Thank you for viewing Organic compounds -- part of the class 532-570 series patents on the FreshPatents.com website. These are patent applications which have been filed in the United States. There are a variety ways to browse Organic compounds -- part of the class 532-570 series patent applications on our website including browsing by date, agent, inventor, and industry. If you are interested in receiving occasional emails regarding Organic compounds -- part of the class 532-570 series patents we recommend signing up for free keyword monitoring by email.
Results in 0.37794 seconds